The National Institutes of Health (NIH) intends to award a non-competitive contract to Bio-Rad Laboratories for a Bio-Rad ChemiDoc Go Imaging System to support prostate cancer research at the Genitourinary Malignancies Branch. The current system is non-functional and discontinued by the manufacturer, making replacement essential for routine laboratory workflows. The acquisition will not exceed the simplified acquisition threshold of $350,000. Performance of services will be at the NIH facility in Bethesda, Maryland. Interested parties must submit responses by July 9, 2026, to be considered.